Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
39 rows where has_cryoEM = 1, surface_class = "A_assoc" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
tier 1
- Tier 1.5 · 39 ✖
surface_class 1
- A_assoc · 39 ✖
has_structure 1
- 1 39
has_cryoEM 1
- 1 · 39 ✖
has_activation_state_pdb_pair 1
- 0 39
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P04180 | LCAT | Phosphatidylcholine-sterol acyltransferase | Tier 1.5 | 0.848 | 1 | A_assoc | 7 | 86.75 | 1 | 0 | 0 | 0 | 1 | Fish-eye disease | 0.8273460309828392 | |||
| Q15582 | TGFBI | Transforming growth factor-beta-induced protein ig-h3 | Tier 1.5 | 0.847 | 1 | A_assoc | 10 | 90.25 | 1 | 0 | 0 | 0 | 1 | lattice corneal dystrophy type I | 0.8242841141270143 | |||
| P07225 | PROS1 | Vitamin K-dependent protein S | Tier 1.5 | 0.847 | 1 | A_assoc | 3 | 82.94 | 1 | 0 | 1 | 2 | 36859809, 33674695 | 1 | thrombophilia due to protein S deficiency, autosomal dominant | 0.8240418292042652 | ||
| P07942 | LAMB1 | Laminin subunit beta-1 | Tier 1.5 | 0.84 | 1 | A_assoc | 3 | 76.69 | 1 | 0 | 0 | 0 | 1 | cobblestone lissencephaly without muscular or ocular involvement | 0.8016665947624902 | |||
| P39060 | COL18A1 | Collagen alpha-1(XVIII) chain | Tier 1.5 | 0.836 | 1 | A_assoc | 9 | 50.62 | 1 | 0 | 1 | 2 | 36707842, 23679916 | 1 | Knobloch syndrome 1 | 0.7867122552672962 | ||
| P35858 | IGFALS | Insulin-like growth factor-binding protein complex acid labile subunit | Tier 1.5 | 0.833 | 1 | A_assoc | 1 | 90.56 | 1 | 0 | 0 | 0 | 1 | Reduced insulin like growth factor binding protein acid labile subunit concentration | 0.7760522769257892 | |||
| P02748 | C9 | Complement component C9 | Tier 1.5 | 0.829 | 1 | A_assoc | 9 | 78.75 | 1 | 0 | 1 | 10 | 41636061, 40411682, 36428893, 36290981, 35247355, 28794177, 27836219, 22678933, 19261617, 15687383 | 1 | Immunodeficiency due to a late component of complements deficiency | 0.761965409699055 | ||
| O15230 | LAMA5 | Laminin subunit alpha-5 | Tier 1.5 | 0.828 | 1 | A_assoc | 2 | 79.12 | 1 | 0 | 0 | 0 | 1 | nephrotic syndrome, IIa 26 | 0.7594872666460903 | |||
| O60568 | PLOD3 | Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 | Tier 1.5 | 0.815 | 1 | A_assoc | 18 | 91.38 | 1 | 0 | 0 | 0 | 1 | bone fragility with contractures, arterial rupture, and deafness | 0.7159150369336311 | |||
| Q99988 | GDF15 | Growth/differentiation factor 15 | Tier 1.5 | 0.775 | 1 | A_assoc | 4 | 75.69 | 1 | 0 | 1 | 29 | 41924874, 41862097, 38879214, 38477735, 37982669, 36927042, 36638554, 36508319, 36333824, 35762561, 33334063, 32527800, 31988066, 29992704, 39884764, 38497478, 38296402, 37162508, 32739349, 30335547 | 1 | hyperemesis gravidarum | 0.5821658682742563 | ||
| P10646 | TFPI | Tissue factor pathway inhibitor | Tier 1.5 | 0.768 | 1 | A_assoc | 9 | 73.62 | 1 | 0 | 1 | 28 | 32366845, 32224381, 30994257, 30302740, 27563744, 27196067, 24263002, 23528042, 22951415, 22658294, 22632032, 22239993, 21696535, 21389323, 8578509, 25521966, 24319161 | 1 | hemophilia A | 0.5591056672248635 | ||
| P02771 | AFP | Alpha-fetoprotein | Tier 1.5 | 0.765 | 1 | A_assoc | 5 | 88.94 | 1 | 0 | 1 | 195 | 41849903, 41732103, 41688234, 41327249, 41051792, 40839965, 40750207, 40684729, 40578247, 40383027, 40381048, 40347636, 40262341, 40216053, 39982565, 39942588, 39890683, 39771616, 39479488, 39383727, 39305942, 39167423, 39140150, 39082193, 39067928, 39007743, 38904836, 38852341, 38356334, 37836778, 37709445, 37606762, 37366993, 37303825, 37295202, 37284243, 37228865, 37104032, 36989661, 36979562, 36842207, 36693188, 36512161, 36389169, 36290918, 36240195, 36130652, 35969067, 35793076, 35747812, 41637558, 41575587, 41123957, 41103270, 40349714, 40286895, 38899396, 37325361 | 1 | Congenital deficiency in alpha-fetoprotein | 0.5500580170557311 | ||
| P24593 | IGFBP5 | Insulin-like growth factor-binding protein 5 | Tier 1.5 | 0.711 | 1 | A_assoc | 3 | 76.06 | 1 | 0 | 1 | 4 | 39317671, 31930684 | 1 | hypothyroidism | 0.3702458751451027 | ||
| Q00604 | NDP | Norrin | Tier 1.5 | 0.707 | 1 | A_assoc | 11 | 83.56 | 1 | 0 | 1 | 2 | 39057719, 11352723 | 0 | Norrie disease | 0.8566451682188412 | ||
| O43866 | CD5L | CD5 antigen-like | Tier 1.5 | 0.706 | 1 | A_assoc | 4 | 85.88 | 1 | 0 | 1 | 3 | 40215752, 37100807 | 1 | functional neutrophil defect | 0.3529395470693119 | ||
| P10145 | CXCL8 | Interleukin-8 | Tier 1.5 | 0.706 | 1 | A_assoc | 21 | 88.06 | 1 | 0 | 1 | 15 | 39564692, 35821507, 31985806, 29268188, 41866852, 37732574, 37016361, 36037714, 35197258, 34884636, 25998051, 24129312 | 1 | coronary artery disease | 0.35357870191996843 | ||
| P80162 | CXCL6 | C-X-C motif chemokine 6 | Tier 1.5 | 0.699 | 1 | A_assoc | 2 | 81.0 | 1 | 0 | 1 | 3 | 40008515, 36649818, 32628701 | 1 | neurodegenerative disease | 0.3309117033683961 | ||
| O95970 | LGI1 | Leucine-rich glioma-inactivated protein 1 | Tier 1.5 | 0.697 | 1 | A_assoc | 9 | 92.56 | 1 | 0 | 0 | 0 | 0 | autosomal dominant epilepsy with auditory features | 0.8225657483127345 | |||
| P03971 | AMH | Anti-Muellerian hormone | Tier 1.5 | 0.685 | 1 | A_assoc | 3 | 68.62 | 1 | 0 | 1 | 2 | 41101154, 27364573 | 0 | persistent Mullerian duct syndrome | 0.7847328444470535 | ||
| P19876 | CXCL3 | C-X-C motif chemokine 3 | Tier 1.5 | 0.679 | 1 | A_assoc | 2 | 81.88 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.26311734927710556 | |||
| P19875 | CXCL2 | C-X-C motif chemokine 2 | Tier 1.5 | 0.674 | 1 | A_assoc | 4 | 81.62 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.24624512698601778 | |||
| O95631 | NTN1 | Netrin-1 | Tier 1.5 | 0.648 | 1 | A_assoc | 5 | 88.5 | 1 | 0 | 0 | 0 | 0 | mirror movements 4 | 0.6611393488240481 | |||
| Q9NWU2 | GID8 | Glucose-induced degradation protein 8 homolog | Tier 1.5 | 0.631 | 1 | A_assoc | 1 | 91.94 | 1 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.10187555420552867 | |||
| Q6IBW4 | NCAPH2 | Condensin-2 complex subunit H2 | Tier 1.5 | 0.62 | 1 | A_assoc | 1 | 62.41 | 1 | 0 | 0 | 0 | 0 | cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | 0.5674645203025676 | |||
| Q15726 | KISS1 | Metastasis-suppressor KiSS-1 | Tier 1.5 | 0.618 | 1 | A_assoc | 2 | 59.41 | 1 | 0 | 1 | 1 | 35026192 | 0 | hypogonadotropic hypogonadism | 0.5608645918536114 | ||
| P22466 | GAL | Galanin peptides | Tier 1.5 | 0.613 | 1 | A_assoc | 10 | 66.56 | 1 | 0 | 1 | 27 | 40382399, 40371468, 39772541, 39705316, 39681229, 39430968, 39329806, 39263318, 38487245, 38314707, 37737989, 37610431, 37512948, 36795559, 36194889, 34944985, 34635237, 33769582, 33006019, 32502344, 31778957, 31173420, 30650243, 29808997, 25940316, 21850727, 9546673 | 0 | temporal lobe epilepsy | 0.5442263564708273 | ||
| Q63HQ2 | EGFLAM | Pikachurin | Tier 1.5 | 0.574 | 1 | A_assoc | 3 | 80.56 | 1 | 0 | 0 | 0 | 0 | mathematical ability | 0.41387833248094535 | |||
| Q8NEV9 | IL27 | Interleukin-27 subunit alpha | Tier 1.5 | 0.573 | 1 | A_assoc | 4 | 75.62 | 1 | 0 | 1 | 2 | 35859339, 32784904 | 0 | Crohn's disease | 0.40963715551754365 | ||
| P01282 | VIP | VIP peptides | Tier 1.5 | 0.55 | 1 | A_assoc | 5 | 67.62 | 1 | 0 | 1 | 24 | 41292425, 40957130, 40403614, 40056883, 39952883, 38763821, 37527574, 36669289, 36129574, 35879297, 35436736, 33990848, 33688885, 31689596, 31403149, 30167802, 30069577, 29708252, 28441340, 27542489, 27334718, 27088368, 26802746, 25782595 | 0 | uterine fibroid | 0.3332844575068197 | ||
| O14960 | LECT2 | Leukocyte cell-derived chemotaxin-2 | Tier 1.5 | 0.542 | 1 | A_assoc | 4 | 92.44 | 1 | 0 | 1 | 2 | 35045701 | 0 | neurodegenerative disease | 0.30565036648724025 | ||
| Q06141 | REG3A | Regenerating islet-derived protein 3-alpha | Tier 1.5 | 0.539 | 1 | A_assoc | 4 | 89.0 | 1 | 0 | 1 | 2 | 39695715, 24771595 | 0 | alcohol drinking | 0.29724052454892086 | ||
| M5A8F1 | ERVH48-1 | Suppressyn | Tier 1.5 | 0.519 | 1 | A_assoc | 1 | 74.94 | 1 | 0 | 0 | 0 | 0 | hypertension | 0.23115391486595976 | |||
| P01178 | OXT | Oxytocin-neurophysin 1 | Tier 1.5 | 0.514 | 1 | A_assoc | 4 | 83.81 | 1 | 0 | 1 | 1 | 34649198 | 0 | neurodegenerative disease | 0.21368454441108417 | ||
| Q5T4W7 | ARTN | Artemin | Tier 1.5 | 0.512 | 1 | A_assoc | 5 | 75.0 | 1 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.20507822956537197 | |||
| P09683 | SCT | Secretin | Tier 1.5 | 0.495 | 1 | A_assoc | 3 | 65.88 | 1 | 0 | 1 | 2 | 17495522, 7752141 | 0 | idiopathic pulmonary fibrosis | 0.14866387905285056 | ||
| Q07325 | CXCL9 | C-X-C motif chemokine 9 | Tier 1.5 | 0.486 | 1 | A_assoc | 1 | 87.44 | 1 | 0 | 1 | 7 | 42046114, 37395276, 35204399, 35018777, 33742062, 27959341, 27819142 | 0 | neoplasm | 0.1199067650750674 | ||
| Q8IZI9 | IFNL3 | Interferon lambda-3 | Tier 1.5 | 0.484 | 1 | A_assoc | 3 | 84.81 | 1 | 0 | 0 | 0 | 0 | hepatocellular carcinoma | 0.1145400757875244 | |||
| O00230 | CORT | Cortistatin | Tier 1.5 | 0.484 | 1 | A_assoc | 5 | 62.84 | 1 | 0 | 0 | 0 | 0 | neoplasm | 0.11461560504839655 | |||
| Q9Y5Q6 | INSL5 | Insulin-like peptide INSL5 | Tier 1.5 | 0.477 | 1 | A_assoc | 3 | 64.06 | 1 | 0 | 0 | 0 | 0 | polycystic ovary syndrome | 0.08868171274230166 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;